LOGIN
Measuring the Ratio of MMP-1:TIMP-1 After Prolotherapy For Frozen Shoulder
March 2024
Measuring the Ratio of MMP-1:TIMP-1 After Prolotherapy For Frozen Shoulder
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
The level of ratio between matrix metalloproteinase-1 (MMP-1) and tissue inhibitor matrix metalloproteinase-1 (TIMP-1) after prolotherapy intervention and the functional outcome in patient with frozen shoulder: A randomized controlled trial.
Medicine (Baltimore) . 2023 Jul 28;102(30):e34356.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
51 patients between the ages of 35 and 70 years with chronic frozen shoulder (FS) were included in this retrospective, double blind trial in which patients were randomly allotted to undergo prolotherapy (PT; n=19) or normal saline injections (NS; n=20). The primary outcomes of interest was the change in the ratio of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of matrix metalloproteinas...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.